Quarterly report pursuant to Section 13 or 15(d)

Revenue Information

v3.19.1
Revenue Information
 3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Revenue Information

Note 10 – Revenue Information

 

Revenue by product lines was as follows:

 

    Three Months Ended  
    March 31,  
Product Line   2019     2018  
MicroParticle Catalyzed Biosensor (“MPC”)   $ 23,320     $ 18,950  
Particle ImmunoFiltration Assay (“PIFA”)     576,317       259,983  
Rapid Enzymatic Assay (“REA”)     -       9,900  
Other     12,486       13,642  
Total Revenue   $ 612,123     $ 302,475  

 

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Three Months Ended  
    March 31,  
Geographic Region   2019     2018  
United States   $ 612,123     $ 294,733  
Rest of World     -       7,742  
Total Revenue   $ 612,123     $ 302,475  

 

The Company had long-lived assets totaling $14,760 and $74,339 located in the People’s Republic of China and $296,670 and $1,272,816 located in the United States as of March 31, 2019 and December 31, 2018, respectively.